{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:02:59Z","timestamp":1769508179517,"version":"3.49.0"},"reference-count":31,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Pleural mesothelioma (PM) frequently recurs despite multimodal therapy. Here, we aimed to retrospectively evaluate the safety and potential clinical benefit of radiofrequency ablation (RFA) for recurrent PM. Methods: Fourteen consecutive patients underwent CT-guided RFA between July 2019 and June 2025. The cohort comprised 13 men and 1 woman, with a median age of 69 (range, 54\u201377) years. All patients had previously received systemic therapy, and 12 had undergone surgery. Seven patients (50%) presented with multiple lesions, and 25 tumors (median diameter 1.8 cm; range, 0.5\u20137.0 cm) were treated in 23 sessions. Outcomes assessed were local tumor control, complications, and survival. Local progression and overall survival were estimated using Kaplan\u2013Meier analysis. Adverse events were classified according to the Society of Interventional Radiology guidelines. Results: Technical success was achieved in all sessions. Two tumors showed local recurrence, corresponding to 1- and 2-year local progression rates of 10.6%. Seven patients showed distant metastases, most of whom subsequently received systemic therapy. Three patients died, two from disease progression and one from treatment-related gastrointestinal perforation during therapy for an unrelated cancer. The overall survival rates were 100%, 100%, and 60% at 1, 3, and 5 years, respectively. Major and minor complications occurred in one case each (4.3%): a refractory skin ulcer and retroperitoneal hematoma, respectively. Conclusions: RFA was technically feasible and generally well tolerated and helped achieve encouraging local control and survival in patients with recurrent PM, warranting further evaluation of RFA as a complementary approach in multimodal treatment strategies.<\/jats:p>","DOI":"10.3390\/cancers18030381","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T12:41:16Z","timestamp":1769431276000},"page":"381","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiofrequency Ablation for Recurrent Pleural Mesothelioma"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6883-834X","authenticated-orcid":false,"given":"Hiroshi","family":"Kodama","sequence":"first","affiliation":[{"name":"Department of Radiology, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8007-1516","authenticated-orcid":false,"given":"Kozo","family":"Kuribayashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Hematology, Hyogo Medical University, Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyuki","family":"Takaki","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Shinkai","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9134-1165","authenticated-orcid":false,"given":"Reona","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ogasawara","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Department of Surgery, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Hematology, Hyogo Medical University, Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7421-8457","authenticated-orcid":false,"given":"Toshiyuki","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Hematology, Hyogo Medical University, Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Funaki","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Department of Surgery, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kijima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Hematology, Hyogo Medical University, Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Yamakado","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"107511","DOI":"10.1016\/j.rmed.2023.107511","article-title":"Comprehensive clinical overview of malignant pleural mesothelioma","volume":"222","author":"Khan","year":"2024","journal-title":"Respir. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bertin, B., Zugman, M., and Schvartsman, G. (2023). The current treatment landscape of malignant pleural mesothelioma and future directions. Cancers, 15.","DOI":"10.3390\/cancers15245808"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-2600(24)00119-X","article-title":"Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): A phase 3 randomised controlled trial","volume":"12","author":"Lim","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): A multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMra1912719","article-title":"Perspectives on the treatment of malignant pleural mesothelioma","volume":"385","author":"Janes","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"108353","DOI":"10.1016\/j.intimp.2021.108353","article-title":"Adverse events of immunotherapy in non-small cell lung cancer: A systematic review and network meta-analysis","volume":"102","author":"Zhou","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2016.67.2675","article-title":"Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) as Part of Lung-Sparing Multimodality Therapy in Patients with Malignant Pleural Mesothelioma","volume":"34","author":"Rimner","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JTO.0b013e31827740f0","article-title":"Patterns of Failure, Toxicity, and Survival After Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma","volume":"8","author":"Gomez","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","article-title":"Fatal Pneumonitis Associated with Intensity-Modulated Radiation Therapy for Mesothelioma","volume":"65","author":"Allen","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.athoracsur.2019.11.048","article-title":"clinical outcomes with recurrence after pleurectomy\/decortication for malignant pleural mesothelioma","volume":"109","author":"Nakamura","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/OP.21.00426","article-title":"Management of advanced pleural mesothelioma\u2014At the crossroads","volume":"18","author":"Nowak","year":"2022","journal-title":"JCO Oncol. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/jrr\/rrab127","article-title":"Survey of malignant pleural mesothelioma treatment in Japan: Patterns of practice and clinical outcomes in tomotherapy facilities","volume":"63","author":"Murai","year":"2022","journal-title":"J. Radiat. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1148\/radiol.2020191272","article-title":"Three-year survival rate after radiofrequency ablation for surgically resectable colorectal lung metastases: A prospective multicenter study","volume":"294","author":"Hasegawa","year":"2020","journal-title":"Radiology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/annonc\/mdv037","article-title":"Radiofrequency ablation is a valid treatment option for lung metastases: Experience in 566 patients with 1037 metastases","volume":"26","author":"Deschamps","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1148\/radiol.14132958","article-title":"Image-guided tumor ablation: Standardization of terminology and reporting criteria\u2014A 10-year update","volume":"273","author":"Ahmed","year":"2014","journal-title":"Radiology"},{"key":"ref_16","first-page":"330","article-title":"Radiofrequency Ablation (RFA) of Renal Cell Carcinoma (RCC): Experience in 200 Tumors","volume":"24","author":"Wah","year":"2014","journal-title":"Eur. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvir.2022.10.011","article-title":"Adverse event classification: Clarification and validation of the Society of Interventional Radiology specialty-specific system","volume":"34","author":"Baerlocher","year":"2023","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1148\/rg.324105181","article-title":"Radiofrequency Ablation of Lung Tumors: Imaging Features of the Postablation Zone","volume":"32","author":"Abtin","year":"2012","journal-title":"Radiographics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2214\/ajr.185.1.01850064","article-title":"Radiofrequency ablation of renal cell carcinoma: Part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors","volume":"185","author":"Gervais","year":"2005","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/PPO.0b013e318209176f","article-title":"Radiofrequency Ablation: A Safe and Effective Treatment in Nonoperative Patients with Early-Stage Lung Cancer","volume":"17","author":"Healey","year":"2011","journal-title":"Cancer J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1016\/j.athoracsur.2017.12.039","article-title":"Radiofrequency ablation effectively treated focal recurrence of mesothelioma","volume":"105","author":"Nakamura","year":"2018","journal-title":"Ann. Thorac. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","article-title":"Society of Interventional Radiology clinical practice guidelines","volume":"14","author":"Sacks","year":"2003","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"ref_24","first-page":"275","article-title":"Percutaneous Thermal Ablation of Primary Lung Cancer and Lung Metastases","volume":"301","author":"Catena","year":"2021","journal-title":"Radiology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.21037\/cco.2019.12.09","article-title":"Advances in percutaneous lung tumor therapy: 2019 update","volume":"8","author":"Kodama","year":"2019","journal-title":"Chin. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/1759-7714.12258","article-title":"Radiofrequency ablation (RFA) for palliative treatment of painful non-small cell lung cancer (NSCLC) rib metastasis: Experience in 12 patients","volume":"6","author":"Hu","year":"2015","journal-title":"Thorac. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10147-013-0640-8","article-title":"Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates","volume":"19","author":"Yamakado","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Efthymiou, E., Charalampopoulos, G., Velonakis, G., Grigoriadis, S., Kelekis, A., Kelekis, N., and Filippiadis, D. (2023). Ablative techniques for sarcoma metastatic disease: Current role and clinical applications. Medicina, 59.","DOI":"10.3390\/medicina59030485"},{"key":"ref_29","first-page":"911","article-title":"Midterm local efficacy and survival after radiofrequency ablation of lung tumors: A single-center experience","volume":"270","author":"Hakime","year":"2014","journal-title":"Radiology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"104685","DOI":"10.4061\/2011\/104685","article-title":"Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review","volume":"2011","author":"Minami","year":"2011","journal-title":"Int. J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.21873\/anticanres.17244","article-title":"True Benefits of Immune Checkpoint Inhibitors in the Treatment of Malignant Pleural Mesothelioma in Japan","volume":"44","author":"Kuribayashi","year":"2024","journal-title":"Anticancer. Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/381\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T12:53:29Z","timestamp":1769432009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cancers18030381"],"URL":"https:\/\/doi.org\/10.3390\/cancers18030381","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]}}}